Business Information for R&D and Strategic Planning



Similar documents
Biomedical Business: Current Trends, Product Challenges and Future Outlook

2014 Wells Fargo Healthcare Conference June 17, 2014 NYSE: Q

Discover more, discover faster. High performance, flexible NLP-based text mining for life sciences

What Lies Ahead? Trends to Watch: Health Care Product Development in North America

Clinical Trial Trends Outline Complexity for Supply Chain. Scott Ohanesian, VP Commercial Operations APAC

THE BIOTECH & PHARMACEUTICAL INDUSTRY

Oracle Buys Phase Forward Expands Oracle s solutions for the life sciences and healthcare industries

Achieving Regulatory Success: Areas of focus for biotechnology companies. Michael J. Schlosser, PhD, DABT April 21, 2013

Driving Innovation in Licensing Through Competitive Intelligence and Big Data Analytics

Xarelto-Drug Insights,2014

Orphan Pharma: pathfinders for an increasingly specialised industry

e-clinical Trial Solutions Market to 2018

A Product and Pipeline Analysis of the Multiple Sclerosis Therapeutics Market

U.S. Contract Research Outsourcing Market: Trends, Challenges and Competition in the New Decade. N8B7-52 December 2010

Careers in Medical and Scientific Writing

How To Use Data Analysis To Get More Information From A Computer Or Cell Phone To A Computer

Iron Deficiency Anemia- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment,

The Myelin Repair Foundation: Accelerating New Treatments for Multiple Sclerosis and All Diseases. Scott Johnson CEO, President and Founder

Cost of Developing a New Drug

PharmaPendium. The definitive source of best-in-class drug information

Agile Master Data Management TM : Data Governance in Action. A whitepaper by First San Francisco Partners

MSD Information Technology Global Innovation Center. Digitization and Health Information Transparency

Europe Rheumatoid Arthritis Market Highlights

Quality by Design Concept

MASTER OF PHILOSOPHY IN BIOSCIENCE ENTERPRISE

Raising Capital for Life Sciences Companies US IPOs, Mezzanine Rounds, Strategic Partnerships and License Agreements

Account Management in times of economic crisis

OPKO Health to Acquire Bio-Reference Laboratories

Company Presentation

BioMed Partners. The rocky way from science to market. Dr. Karsten Fischer BioMedPartners AG. VPM Days Hannover

Xarelto (Atrial Fibrillation) - Analysis and Forecasts to 2022

TABLE OF CONTENTS International Transfer Pricing in the Ethical Pharmaceutical Industry Second edition

TIBCO Spotfire Helps Organon Bridge the Data Gap Between Basic Research and Clinical Trials

BEST PRACTICES RESEARCH

Normand Laberge Vice-President Regulatory & Scientific Affairs Rx&D. Globalization of Clinical Research: Trends & Implications for Canada

Why Are Drugs So Expensive? Learning About the Drug Development Process

Product Life Cycle Management in Life Sciences Industry

An Introduction to Genomics and SAS Scientific Discovery Solutions

Salary Survey Domestic, International Salary Survey and Country Cost Analysis

Outlook of China Biopharmaceutical Outsourcing Market

Sample-Global Big Data Market in the Healthcare Sector. technavio insights

Big Data An Opportunity or a Distraction? Signal or Noise?

Introduction to Bureau Van Dijk

MSc program Pharmaceutical Design and Engineering. Peter Heegaard, Head of Studies DTU Veterinary

Presented at: Jefferies 2015 Global Healthcare Conference

Informatics and Knowledge Management at the Novartis Institutes for BioMedical Research (NIBR)

CLINICAL DEVELOPMENT OPTIMIZATION

Bayer Invests Heavily in R&D and is committed to innovation Sustained Innovation Output from all Subgroups

A leader in the development and application of information technology to prevent and treat disease.

Global regulatory affairs role in the biopharmaceutical industry

Global outlook: Healthcare

Strategic Consulting Services

Toward Acceleration of Open Innovation

TABLE OF CONTENTS. Introduction...1. Chapter1 AdvancesinTreatment...2. Chapter2 MedicinesinDevelopment Chapter3 ValueandSpending...

Nanomedicine in Horizon 2020

Translational research infrastructure in Neurosciences /Bruxelles

Emerging Clinical Sites: India and China. Patrycja Doba, Clinical Research Coordinator

White Paper CLINICAL RESEARCH IN POLAND AN INTRODUCTION

A career on the science park

Therapy Trends: Rheumatoid Arthritis -- KOL Insight Module

Elements for optimising Orphan drug development industry perspective

Global Multiple Sclerosis Epidemiology and Patient Flow Analysis

Brochure More information from

Global Multiple Myeloma Epidemiology and Patient Flow Analysis

Global Haemophilia Epidemiology and Patient Flow Analysis

Join our scientific talent community

Battelle Battelle s Technology Partnership Practice (TPP) Pharmaceutical Research and Manufacturers of America (PhRMA)

Global Market Study on E-clinical Solution Software: Asia to Witness Highest Growth by 2020

Keys to success in multi-channel marketing in Japan

THOMSON REUTERS CORTELLIS FOR INFORMATICS. REUTERS/ Aly Song

Multiple Sclerosis Treatments: World Market Outlook to 2011

Accessible intelligence for decision makers

IPROVE Innovation Partnership for a Roadmapon VaccinesinEurope

An Overview of the Life Sciences and Outsourcing Landscape in India: Spotlight on Bangalore

Valuations. The Effect of the Credit Crunch, US Healthcare Reform and the Shortage of New Innovative Products. Medius Associates.

Project Management. Dissemination and Exploitation Services in Horizon 2020

SILOBREAKER ENTERPRISE SOFTWARE SUITE

Avastin (Renal Cell Carcinoma) - Analysis and Forecasts to 2022

Xarelto-API Insights. Brochure More information from

In-depth analysis of the report is based on propriety databases, primary and secondary research and inhouse analysis by a team of experts.

APAC Contract Research Organisation (CRO) Market

2016 Industry Survey Pursuing World Class RIM: Strategy, Measures and Priorities. Study Fast Facts

Transcription:

Business Information for R&D and Strategic Planning Identifying Issues and Selecting Sources Shaida Dorabjee Information Consultant shaida@sdis.co.uk www.sdis.co.uk Pharma-Bio-Med, Dubrovnik. 2-5 November 2008

Your role in the organisation Marketing the information service Reviewing and auditing the service The importance of business information

Business Information Understand the business To plan your strategy To provide the right service Provide R&D information to business colleagues Keep up to date with business information sources

The R&D business issues New therapies, biomarkers, genomics Regulatory pressures focus on safety, economic assessment Patients consumer power, ageing population Initiatives: FDA s US Critical Path Initiative and EFPIA s Innovative Medicines Initiative or EMEA s Roadmap to 2010 New R&D Strategies Investors

Rethinking R&D strategies Decentralise R&D Team approach Focus on disease biology Focus on disease-relevant molecular pathways Partnerships Navigating the Drug Discovery Landscape. Decision Resources March 2008

The changing R&D process Discovery & Pre-clinical development Clinical trials Phase I Phase II Phase III Regulatory Review Market Incremental vs breakthrough innovation Less bureaucracy more science Emphasis on post-approval studies Learn (Discovery to proof of concept) Confirm (Proof of concept to submission) Build (Discovery to proof of concept) Confirm (Provisional approval) Expand (Updated safety data and clinical outcome) Basic Research (Understanding biology and disease) Translational Research (Concept to clinical evaluation) Critical Path Research (Improving product development).

Investor power Traditionally financial institutions - investment banks and venture capitalists Pension funds eg Pharma Futures

Pharma Futures Group of three pension funds and industry representatives Dialogue to ensure that funds managed maximise value over the long term The pension funds have invested $20bn in healthcare Interest in R&D Interested in better understanding of process and productivity in Phases I and II, and quality

Quality Quality of the pipeline, how quality changes over time and understanding the underlying factors that affect quality. Percentage of me-too s vs novel drugs Degree of diversification of the pipeline Progression within pipeline Rates and reasons for attrition Basic R&D information is becoming key to supporting the business and for strategic planning Pharma Futures Report: Prescription for long-tern value. 2007

So what Who is a member of the Pharma Futures Working Group? Where do they get their R&D information from? Who are the your collaborators in the provision of this information? Where do you go to keep up to date with business information?.

Sources of Business Information

News Alerts, RSS feeds, mobile, blogs etc Google BBC News Yahoo News Moreover w.moreover.com aggregated web news and blogs service Firstword www.firstwordplus.com Pharma news

Moreover RSS feeds

Firstword

Dow Jones dowjones.com FT www.ft.com PRNewswire www prnewswire.com.fr.uk NewsEdge.com www.acquiremedia.com News and industry information (with taxonomy and tags) Dailydrugnews.com ThomsonReuters; pipeline news Pipelinereview.com R&D News and highlights Pharmalive.com Also Med Ad news and R&D Directions ReutersHealth.com Medical and healthcare news FTP or via website

Newsletters Scrip Newsletter BioCentury Business intelligence for Biotech and Pharma MedAdNews Part of PharmaLive family (R&D Directions) Marketletter Global pharma, generic and bio tech business news Fiercepharma and Fiercebiotech Daily monitor

Fiercebiotech Free newsletter, comments on articles; Research Reports eg Innovative Strategies and Models for R&D Success

IMS www1.imshealth.com Market Research Data Originally data collection, now analysis, solutions, and consulting Tracks over 70% global sales Covers 100 countries Information on 260 million anonymised patients Reports/services IMS Lifecycle (including R&D Focus,New Product and Patent Focus) IMS World Review IMS Knowledge Link (sales, company and R&D info)

Business Information Frost & Sullivan frost.com Company and industry reports Research and marketing services Eg Globalisation of clinical trials Datamonitor datamonitor.com Data analysis and forecasting Briefings Reports Eg The Pharmaceutical Industry 2008: Current and Future Trends and Strategic Issues Shaping Pharma

Decision Resources decisionresources.com > 150 reports each year. Specific diseases or areas and analysis of key issues facing the biopharmaceutical industry today Eg Navigating the Drug Discovery Landscape: A Strategic Overview of Pharmaceutical R&D EvaluatePharma evaluatepharma.com Forecasting and analysis 900 companies R&D to market Eg World Review 2012 Part of Informa

EvaluatePharma Plus Financial data, News releases etc

Market Research Reports Mindbranch.com Researchandmarkets.com Marketresearch.com Piribo.com Online business intelligence for the Biopharma industry. 3601 Reports. Espicom.com Aggregators Pharmaceuticals and Devices business intelligence Market research reports

Piribo

Business/Economics The Economist www.economist.com Analysis of world business and current affairs, insight and opinion on international news, finance, science and technology. Surveys, Country reports, Backgrounders. Practical guides and dictionary of business terms E.I.U. Country, industry and management analysis www.eiu.com Business Monitor International www.businessmonitor.com global emerging markets, plus pharma sector

Company information Dun & Bradstreet www.dnb.com Dun Business information for credit, marketing and purchasing decisions worldwide KBE Key British Enterprises (ekbe); Who Owns Whom (ewow) Bureau van Dijk bvdep.com 7 million companies in Europe ICC International icc.co.uk 22 million European companies Company directories Eg Major Pharmaceutical & Biotechnology Companies of the World 2008 via www.dataresources.co.uk

Information on Company web sites Investor Information Share info, shareholder info, Stock information, SEC filings, financial results, Annual Report, pipeline info Media Section News, archives, photo library (people and locations)

Quality Sources used Up to date Verified with originator Benchmark against best practice Re-used information

CMR International 2008 Pharmaceutical R&D Fact Book http://cmr.thomsonreuters.com Parexel Bio/Pharma R&D Statistical Sourcebook 2008/2009 OECD OECD Health Data 2008 Health at a Glance WHO Statistical Information System www.who.int/whosis Facts and Figures

OECD Heath publications

WHO Health Indicators.

Consultants PWC www.pwc.com eg Pharma 2020: Virtual R&D - Which path will you take? Decision Resources Consulting Pharma and healthcare only www.decisionresources.com BCG www.bcg.com Ernst &Young www.ey.com Annual Global Pharmaceutical and Biotech Reports Accenture www.accenture.com IBM Business Consulting www.ibm.com Focus on IT productivity and processes White papers eg Using high performance computing clusters to accelerate life science solutions ; Pharma 2010: the threshold of innovation

Business Information and MR Organisations European Society for Opinion and Market Research (ESOMAR) www.esomar.org Training, guidelines Market Research Society (MRS) www.mrs.org.uk Code of Conduct, training, events etc SCIP www.scip.org Society for Competitive Intelligence Professionals Institute for Competitive Intelligence www.institutefor-competitive-intelligence.com UK, USA, Germany

Pharmaceutical Marketing Research Group (PMRG) www.pmrg.org Meetings, newsletter etc EphRMA www.ephmra.org European Pharmaceutical Market Research Association BHBIA www.bhbia.org.uk British Healthcare Business Intelligence Organisation PBIRG www.pbirg.com/ Pharmaceutical Business Intelligence Research Group

Search Engines, Portals and Directories Alacra.com/alacrasearch 100 business information databases Scirus.com Scientific information search engine Vascoda.de Portal for scientific information (medpilot.de - DIMDI and German NLM) Bubl.co.uk Selected internet resources Evaluated Intute.ac.uk Web resources for education and research Evaluated

Alacra.com

Alacrawiki.com Guide to business information companies, publishers and databases

BUBL.co.uk (business research)

Intute.ac.uk (Health statistics)

Scirus.com

For the Info Pro Business Information Review journal devoted entirely to the practice of business information provision sagepub.com. VIP Business Information digital magazine that includes in-depth product reviews and comparisons, interviews with senior information industry figures and monitoring of research to identify future trends Vivavip.com Business Information Searcher quarterly publication for business information professionals, CI and knowledge managers written by acknowledged information professionals. dataresources.co.uk

The benefits Better awareness and understanding of your business Forge closer links with other providers of information Raise your profile within the organisation Take a more active role within the organisation

Thank you Shaida Dorabjee shaida@sdis.co.uk www.sdis.co.uk